Wagh P, Savaliya S, Joshi B, Vyas B, Kuperkar K, Lalan M
Drug Deliv Transl Res. 2024; 14(12):3568-3584.
PMID: 39103594
DOI: 10.1007/s13346-024-01658-y.
Verbrugge F, Vangoitsenhoven R, Mullens W, Van der Schueren B, Mathieu C, Tang W
Curr Cardiovasc Risk Rep. 2024; 9(8).
PMID: 38994329
PMC: 11238646.
DOI: 10.1007/s12170-015-0467-0.
Migdanis A, Migdanis I, Koukoulis G
Cureus. 2023; 15(11):e48102.
PMID: 38046763
PMC: 10690064.
DOI: 10.7759/cureus.48102.
Tsunokake S, Iwabuchi E, Miki Y, Kanai A, Onodera Y, Sasano H
Breast Cancer Res Treat. 2023; 201(3):499-513.
PMID: 37439959
DOI: 10.1007/s10549-023-07024-9.
Ji L, Mishra M, De Geest B
Pharmaceutics. 2023; 15(4).
PMID: 37111578
PMC: 10140883.
DOI: 10.3390/pharmaceutics15041092.
Relevance of Sugar Transport across the Cell Membrane.
Carbo R, Rodriguez E
Int J Mol Sci. 2023; 24(7).
PMID: 37047055
PMC: 10094530.
DOI: 10.3390/ijms24076085.
Emerging Role of Sodium-Glucose Co-Transporter 2 Inhibitors for the Treatment of Chronic Kidney Disease.
Isidto R, Danguilan R, Naidas O, Vilanueva R, Arakama M, Paraiso L
Int J Nephrol Renovasc Dis. 2023; 16:43-57.
PMID: 36852177
PMC: 9960786.
DOI: 10.2147/IJNRD.S387262.
SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.
Dutka M, Bobinski R, Francuz T, Garczorz W, Zimmer K, Ilczak T
Cancers (Basel). 2022; 14(23).
PMID: 36497303
PMC: 9738342.
DOI: 10.3390/cancers14235811.
Sodium-glucose Cotransporter 2 Inhibitors' Rise to the Backbone of Heart Failure Management: A Clinical Review.
Rohant N, Kennedy J
Heart Int. 2022; 15(1):42-48.
PMID: 36277321
PMC: 9524703.
DOI: 10.17925/HI.2021.15.1.42.
Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein.
Malinska H, Huttl M, Markova I, Miklankova D, Hojna S, Papousek F
Biomedicines. 2022; 10(9).
PMID: 36140169
PMC: 9495591.
DOI: 10.3390/biomedicines10092066.
Endometrial Glucose Transporters in Health and Disease.
Vrhovac Madunic I, Karin-Kujundzic V, Madunic J, Sola I, Serman L
Front Cell Dev Biol. 2021; 9:703671.
PMID: 34552924
PMC: 8450505.
DOI: 10.3389/fcell.2021.703671.
Mechanisms of Glucose Absorption in the Small Intestine in Health and Metabolic Diseases and Their Role in Appetite Regulation.
Gromova L, Fetissov S, Gruzdkov A
Nutrients. 2021; 13(7).
PMID: 34371983
PMC: 8308647.
DOI: 10.3390/nu13072474.
Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes.
van Meijel L, Tack C, de Galan B
Diabetes Obes Metab. 2021; 23(11):2582-2589.
PMID: 34338413
PMC: 9292159.
DOI: 10.1111/dom.14505.
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?.
Liu J, Tian J, Sodhi K, Shapiro J
J Membr Biol. 2021; 254(5-6):513-529.
PMID: 34297135
PMC: 8595165.
DOI: 10.1007/s00232-021-00192-z.
Inhibition of eIF5A hypusination reprogrammes metabolism and glucose handling in mouse kidney.
Cougnon M, Carcy R, Melis N, Rubera I, Duranton C, Dumas K
Cell Death Dis. 2021; 12(4):283.
PMID: 33731685
PMC: 7969969.
DOI: 10.1038/s41419-021-03577-z.
Cyst formation in proximal renal tubules caused by dysfunction of the microtubule minus-end regulator CAMSAP3.
Mitsuhata Y, Abe T, Misaki K, Nakajima Y, Kiriya K, Kawasaki M
Sci Rep. 2021; 11(1):5857.
PMID: 33712686
PMC: 7954811.
DOI: 10.1038/s41598-021-85416-x.
Regulation of gene expression in chickens by heat stress.
Goel A, Ncho C, Choi Y
J Anim Sci Biotechnol. 2021; 12(1):11.
PMID: 33431031
PMC: 7798204.
DOI: 10.1186/s40104-020-00523-5.
Effects of Xylanase Supplementation and Citric Acid on Performance, Ileal Nutrients Digestibility, and Gene Expression of Intestinal Nutrient Transporters in Broilers Challenged with .
Hosseini S, Manafi M, Nazarizadeh H
J Poult Sci. 2020; 54(2):149-156.
PMID: 32908420
PMC: 7477122.
DOI: 10.2141/jpsa.0160099.
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors.
Margonato D, Galati G, Mazzetti S, Cannistraci R, Perseghin G, Margonato A
Heart Fail Rev. 2020; 26(2):337-345.
PMID: 32901315
PMC: 7895775.
DOI: 10.1007/s10741-020-10024-2.
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.
Gyimesi G, Pujol-Gimenez J, Kanai Y, Hediger M
Pflugers Arch. 2020; 472(9):1177-1206.
PMID: 32767111
PMC: 7462921.
DOI: 10.1007/s00424-020-02433-x.
